Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest abdominal pain Stories

2013-10-16 00:20:40

Phase II Trial to Focus on Moderate to Severe UC Patients with Eotaxin-1 Biomarker TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 16, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Tomer Adar, M.D. at the Digestive Diseases Institute, Shaare Zedek Medical Center, Hebrew University of Jerusalem, presented a poster on October 15, 2013 entitled Inhibition of Eotaxin-1 (CCL 11) Ameliorates DSS-Induced Colitis; A...

2013-10-15 08:30:06

IBS Treatment Center Opening a New Location SEATTLE, Oct. 15, 2013 /PRNewswire/ -- The IBS Treatment Center, which specializes in treating irritable bowel syndrome, announced the opening of a new clinic in Santa Monica, California, in late October. Conveniently located next to the UCLA Medical Center, this new branch of the clinic will provide a progressive approach to digestive health as well as easy access to treatment for patients previously without adequate care. Since 2005,...

2013-10-11 12:24:54

EMBARGOED FOR RELEASE, Monday, October 14, 2013, 8:00 a.m. EDT SAN DIEGO, Oct. 11, 2013 /PRNewswire-USNewswire/ -- More than 4,000 gastroenterologists, physicians and other health care professionals from around the world will convene this week for the American College of Gastroenterology's (ACG) 78(th) Annual Scientific Meeting at the San Diego Convention Center in San Diego, CA, to review and present the latest scientific advances in gastrointestinal research, treatment of digestive...

2013-10-09 08:26:10

THE WOODLANDS, Texas, Oct. 9, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced top-line results from a pilot study exploring the use of telotristat etiprate in ulcerative colitis. Telotristat etiprate, a serotonin synthesis inhibitor, is currently in Phase 3 development for carcinoid syndrome, a condition caused by metastatic, functioning neuroendocrine tumors. Elevated serotonin is a hallmark of carcinoid syndrome, and two previous Phase 2...

2013-10-03 08:57:15

Researchers discover that the cells play a major role in inflammation which underlies Crohn's disease in small intestine Scientists have discovered that Crohn's disease, the inflammatory bowel disorder, can originate from specialized intestinal cell type called Paneth cells. As such, they propose that small intestinal Crohn's disease might be a specific disorder of this cell type, providing a possible new target for treatments. The study, by researchers from the University of Cambridge and...

2013-10-01 23:04:08

HB 1183, which passed the General Assembly and was signed into law by Governor Martin O’Malley on April 18, 2013 expands access to an “employee only” bathroom in retail establishments for Ostomy patients as well as individuals suffering from Crohn’s Disease, Ulcerative Colitis, and other medical conditions that require immediate access to a restroom, when no public restroom facilities are otherwise available. Rockville, MD (PRWEB) October 01, 2013 Metro Maryland Ostomy...

2013-09-28 23:02:43

Diverticulitis Breakthrough is a brand new diverticulitis treatment guide generated by Mark Anastasi, who promises to help sufferers eliminate this disease effectively. A full overview of Diverticulitis Breakthrough on the website Vkool.com indicates if this program is worth buying. Seattle, Wa (PRWEB) September 28, 2013 Diverticulitis Breakthrough made by Mark Anastasi is a comprehensive diverticulitis program that helps people reverse diverticulitis and restore their body to a state of...

Mucus Protects Gut
2013-09-27 13:23:45

Michael Harper for redOrbit.com - Your Universe Online Researchers from the Icahn School of Medicine at Mount Sinai’s Immunology Institute say they’ve discovered an important role played by mucus in the gut. Though little was previously known about mucus, the Icahn doctors say the slimy, sticky stuff acts as an anti-inflammatory in the stomach and provides a protective self-regulating immune function. The research also showed that mucus acts as a protective barrier against bacteria...

2013-09-26 23:24:00

Emergency medicine physician from the Children's Hospital of Philadelphia led study team. Philadelphia, PA (PRWEB) September 26, 2013 Pediatric researchers have found race- and ethnicity-based disparities in pain management and length of stay among children who came to hospital emergency departments for treatment of abdominal pain. A study team reported on their analysis of a national database of hospital visits in the October issue of Pediatrics. Overall, black, Hispanic and...

2013-09-26 23:23:44

Mount Sinai Researchers Discover Mucus Prevents Inflammatory Reactions in the Gut New York, NY (PRWEB) September 26, 2013 Imagine mucus – which most people find unpleasant – actually helping your body maintain its equilibrium, prevent inflammation, and reduce food allergy problems. Researchers from the Icahn School of Medicine at Mount Sinai’s Immunology Institute foresee a day when mucus could be manufactured and given to sick people to help them fight inflammation and increase...